PARIS, 31 AUG 2026 — Pasqal completed its merger with Bleichroeder Acquisition Corp II on 28 August and began trading on Nasdaq as PSQL. Reports of the first-day gain range from 40 to 95 per cent, all of them accurate, and none of them the number that matters.
The figure that is fixed
Pasqal came out of the transaction with approximately US$360m in cash. That number does not move with the share price and it is what the company has to spend.
Everything else quoted about the debut is a snapshot. Bloomberg had the stock up 52 per cent, another account had it up more than 40, a third had it at 43 per cent and US$14 in the early afternoon in New York, and a fourth reported 95. The figures are all consistent with each other; each quotes the price at a different minute of a volatile session.
Why a first-day pop is a weak signal in a SPAC
In a conventional listing, a large first-day rise suggests the offering was priced below what the market would bear. In a SPAC completion it usually means something duller.
A SPAC's shareholders can redeem at around US$10 before the merger closes, and in recent years most of them have. High redemptions leave a small free float, and a small float moves violently on modest volume. A 50 per cent gain on a thin float after redemptions tells you about the float, not about the valuation of the business.
The cash figure is therefore the informative one. US$360m is what survived redemptions plus whatever was raised alongside, and a company that keeps that much through a SPAC completion has done considerably better than the average of the last few years. The pop is a consequence of those mechanics, not independent confirmation of the company's value.
What Pasqal actually builds
Neutral-atom quantum computing, which is a specific approach and not the general-purpose machine the phrase quantum computer usually conjures.
Individual atoms are held in place by focused laser beams in a vacuum chamber and manipulated with further lasers. The attraction is that the qubits are identical by physics — every rubidium atom is the same as every other rubidium atom, which is not true of manufactured superconducting circuits — and that the arrays can be rearranged, which matters for connectivity between qubits.
The company's own framing is unusually direct: state-of-the-art analog quantum computing today, with a clear path toward fault-tolerant quantum computing in the future. Those are two different machines. Analog quantum simulation solves a narrow class of physics and optimisation problems by building a system that behaves like the one you want to study. Fault-tolerant digital quantum computing, which is what would break cryptography or transform chemistry at scale, requires error correction that nobody has yet demonstrated at useful size.
Pasqal sells the first and is working toward the second. Coverage that mentions only quantum computing collapses the distinction.
The number to check is deployments
Seven quantum processing units deployed, three more in production, supporting more than 25 commercial and research applications.
That is a better basis for judgment than a valuation, because a delivered and installed machine has a customer who paid and accepted it. Most companies in this sector have shipped nothing outside their own laboratory, and the gap between a qubit count in a press release and hardware running at a customer site is where the sector's credibility problems live.
Apply the same discipline to it, though. Deployed does not mean commercially useful, and research installations at national laboratories and universities are a different revenue quality from an enterprise buying a machine to solve its own problem. The company has not published a revenue figure, and the split between those two categories is the thing a prospective investor would most want and does not have.
What the founding pedigree does and does not tell you
Pasqal was co-founded by Alain Aspect, who shared the 2022 Nobel Prize in Physics for experiments with entangled photons that established the violation of Bell inequalities.
The physics is real and so is Aspect's association with the company. It is also close to irrelevant to the investment question. What separates quantum companies now is not the soundness of the underlying science, which is solid for all the leading approaches. It is the engineering: whether a path to manufacturing and error correction exists that reaches commercial utility before the funding runs out. That is an engineering and capital question, and a Nobel laureate on the founding team is not evidence about it either way.
Why this matters from here
Singapore, Japan, Australia and China all have funded national quantum programmes, and the procurement question they face is the one this listing raises.
A government buying an analog quantum machine today gets a research instrument and a trained cohort of people, which is a defensible purchase. It does not get a computer that outperforms classical hardware on its own workload. The case for buying is about building capability, not adding compute. Those are different budget lines and conflating them has produced disappointment in every prior wave of specialised hardware.
The listing is useful to the region for a duller reason. A public company files. Deployment counts, revenue and cash burn become checkable quarterly rather than announced selectively, and for a sector that has run on qubit-count press releases for a decade, that is the most valuable thing to come out of this transaction.
